Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexi Vasbinder

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Journal of Medical Virology|January 18, 2024
SuPAR, biomarkers of inflammation, and severe outcomes in patients hospitalized for COVID-19: The International Study of Inflammation in COVID-19Alexi Vasbinder, Kishan Padalia, Ian Pizzo, et al.
The Journal of Clinical Investigation|October 4, 2022
Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosisGeorge Hindy, Daniel J Tyrrell, Alexi Vasbinder, et al.
Journal for Immunotherapy of Cancer|March 3, 2025
Safety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: a multicenter international retrospective studyAmin H Nassar, Sarah Abou Alaiwi, Talal El Zarif, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Journal of Medical Virology|January 18, 2024
SuPAR, biomarkers of inflammation, and severe outcomes in patients hospitalized for COVID-19: The International Study of Inflammation in COVID-19Alexi Vasbinder, Kishan Padalia, Ian Pizzo, et al.
The Journal of Clinical Investigation|October 4, 2022
Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosisGeorge Hindy, Daniel J Tyrrell, Alexi Vasbinder, et al.
Journal for Immunotherapy of Cancer|March 3, 2025
Safety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: a multicenter international retrospective studyAmin H Nassar, Sarah Abou Alaiwi, Talal El Zarif, et al.
Pageof 5